Targeting c-kit in the therapy of mast cell disorders: current update.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Pharmacology

• Publication date

  2012-09-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejphar.2012.06.030PMID 22789565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tyrosine kinase inhibitor sunitinib relieves systemic and oral antigen‐induced anaphylaxes in mice

  2012cited by this paper
• The role of mast cells in allergic inflammation.

  2012cited by this paper
• Anti-allergic effects of nilotinib on mast cell-mediated anaphylaxis like reactions.

  2012cited by this paper
• Effect of Imatinib on Airway Smooth Muscle Thickening in a Murine Model of Chronic Asthma

  2011cited by this paper
• Tyrosine kinase inhibitors in the treatment of systemic mastocytosis.

  2011cited by this paper
• Mast cells squeeze the heart and stretch the gird: their role in atherosclerosis and obesity.

  2011cited by this paper
• Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

  2011cited by this paper
• Irritable bowel syndrome - An inflammatory disease involving mast cells

  2011cited by this paper
• c-Kit is essential for alveolar maintenance and protection from emphysema-like disease in mice.

  2011cited by this paper
• Mast cells in atherosclerosis

  2011cited by this paper
• Mast Cell Infiltration Is Involved in Renal Interstitial Fibrosis in a Rat Model of Protein-Overload Nephropathy

  2010cited by this paper
• Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib.

  2010cited by this paper
• Signaling of c‐kit in dendritic cells influences adaptive immunity

  2010cited by this paper
• Mast cells: novel clinical perspectives from recent insights

  2009cited by this paper
• Tyrosine kinases as targets in rheumatoid arthritis.

  2009cited by this paper
• Concurrent Inhibition of Kit- and FcϵRI-Mediated Signaling: Coordinated Suppression of Mast Cell Activation

  2008cited by this paper
• Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation.

  2008cited by this paper
• Role of mast cells in progressive renal diseases.

  2008cited by this paper
• Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders

  2008cited by this paper
• The development of allergic inflammation

  2008cited by this paper
• Mast Cells

  2008cited by this paper
• The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib

  2007cited by this paper
• Mast cells in the promotion and limitation of chronic inflammation

  2007cited by this paper
• The mast cell and allergic diseases: role in pathogenesis and implications for therapy

  2007cited by this paper
• The allergic cascade: review of the most important molecules in the asthmatic lung.

  2007cited by this paper
• Differential release of mast cell mediators and the pathogenesis of inflammation

  2007cited by this paper
• Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT

  2007cited by this paper
• Mastocytosis: State of the Art

  2007cited by this paper
• Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti‐rheumatic therapy

  2007cited by this paper
• Regulation of mast cell development by inflammatory factors.

  2007cited by this paper
• Kit: molecule of interest for the diagnosis and treatment of mastocytosis and other neoplastic disorders.

  2007cited by this paper
• Efficacy of the Kinase Inhibitor SU11248 against Gastrointestinal Stromal Tumor Mutants Refractory to Imatinib Mesylate

  2006cited by this paper
• Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma

  2006cited by this paper
• The Critical Role of Mast Cells in Allergy and Inflammation

  2006cited by this paper
• Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.

  2006cited by this paper
• PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects.

  2006cited by this paper
• Integrated signalling pathways for mast-cell activation

  2006cited by this paper
• Development, migration, and survival of mast cells

  2006cited by this paper
• Mastocytosis: Pathology, genetics, and current options for therapy

  2005cited by this paper
• Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis

  2005cited by this paper
• Treatment of cockroach allergen asthma model with imatinib attenuates airway responses.

  2005cited by this paper
• Effects of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, on human mast cells bearing wild-type or mutated codon 816 c-kit.

  2005cited by this paper
• The contribution of mast cells to the late-phase of allergic asthma in rats

  2005cited by this paper
• Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells.

  2004cited by this paper
• STI571 inhibits growth and adhesion of human mast cells in culture

  2003cited by this paper
• Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases

  2003cited by this paper
• Cutting Edge: Distinct Toll-Like Receptor 2 Activators Selectively Induce Different Classes of Mediator Production from Human Mast Cells 12

  2003cited by this paper
• Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis

  2002cited by this paper
• Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis

  2000cited by this paper
• The role of c-Kit and its ligand, stem cell factor, in mast cell apoptosis.

  1995cited by this paper
• Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor.

  1995cited by this paper

• Mast Cells in the Solid Tumor Microenvironment: Multiple Roles and Targeted Therapeutic Potential

  2025cites this paper
• Genetic association between inflammatory factors and abdominal aortic calcification: Insights from a genome-wide association study.

  2025cites this paper
• Advances in i-motif structures: Stability, gene expression, and therapeutic applications.

  2025cites this paper
• Circulating Endocannabinoids in Canine Cutaneous Mast Cell Tumor

  2024cites this paper
• Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy.

  2024cites this paper
• Recruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury.

  2024cites this paper
• c-KIT inhibitors reduce pathology and improve behavior in the Tg(SwDI) model of Alzheimer’s disease

  2024influential citation
• Accumulation of Renal Fibrosis in Hyperuricemia Rats Is Attributed to the Recruitment of Mast Cells, Activation of the TGF-β1/Smad2/3 Pathway, and Aggravation of Oxidative Stress

  2023cites this paper
• Cannabidiol Inhibits IgE-Mediated Mast Cell Degranulation and Anaphylaxis in Mice.

  2023cites this paper
• Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell‐mediated diseases

  2023cites this paper
• Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis: A systematic review and meta-analysis from randomized controlled trials

  2022cites this paper
• The exon-skipping oligonucleotide, KitStop, depletes tissue-resident mast cells in vivo to ameliorate anaphylaxis

  2022cites this paper
• A fully human anti-c-Kit monoclonal antibody 2G4 inhibits proliferation and degranulation of human mast cells

  2022cites this paper
• FIGURE 1: OVERVIEW OF DIAGNOSTIC STEPS FOR ADULTS WITH MASTOCYTOSIS

  2021cites this paper
• Ginsenoside Rg1 prevents vascular intimal hyperplasia involved by SDF-1α/CXCR4, SCF/c-kit and FKN/CX3CR1 axes in a rat balloon injury.

  2020cites this paper
• Dasatinib Inhibits Lyn and Fyn Src-Family Kinases in Mast Cells to Suppress Type I Hypersensitivity in Mice

  2020cites this paper
• IMPORTANT HISTOLOGICAL AND IMMUNOCHEMICAL PARAMETERS FOR CLASSIFICATION OF CANINE MAST CELL TUMORS

  2019cites this paper
• New insight into systemic mastocytosis mediated by cytokines IL-1β and IL-33: Potential inhibitory effect of IL-37.

  2019cites this paper
• Involvement of stromal cell-derived factor-1α (SDF-1α), stem cell factor (SCF), fractalkine (FKN) and VEGF in TSG protection against intimal hyperplasia in rat balloon injury.

  2019cites this paper
• Oxidized phospholipids stimulate production of stem cell factor via NRF2-dependent mechanisms

  2018cites this paper
• Genetic background and antenatal risk factors of bronchopulmonary dysplasia

  2018cites this paper
• Local Xenotransplantation of Bone Marrow Derived Mast Cells (BMMCs) Improves Functional Recovery of Transected Sciatic Nerve in Cat: A Novel Approach in Cell Therapy.

  2018cites this paper
• Mast cells improve functional recovery of transected peripheral nerve: A novel preliminary study.

  2017cites this paper
• Familial Progressive Hyperpigmentation, Cutaneous Mastocytosis, and Gastrointestinal Stromal Tumor as Clinical Manifestations of Mutations in the c‐KIT Receptor Gene

  2017cites this paper
• The stem cell factor (SCF)/c-KIT system in carcinogenesis of reproductive tissues: What does the hormonal regulation tell us?

  2017cites this paper
• Different anti-remodeling effect of nilotinib and fluticasone in a chronic asthma model

  2016cites this paper
• Recombinant expression and analysis of tetraspanin extracellular-2 domains

  2016cites this paper
• Mast cells' integrated actions with eosinophils and fibroblasts in allergic inflammation: implications for therapy.

  2015cites this paper
• Polymorphisms of the gene encoding Kit ligand are associated with bronchopulmonary dysplasia

  2015cites this paper
• Masitinib for the treatment of mild to moderate Alzheimer’s disease

  2015cites this paper
• The SCF/c‐KIT system in the male: Survival strategies in fertility and cancer

  2014cites this paper
• Genetic background of spontaneous preterm birth and lung diseases in preterm infants : studies of potential susceptibility genes and polymorphisms

  2014cites this paper
• Targeting mast cells in inflammatory diseases.

  2014cites this paper
• Mast cell histamine promotes the immunoregulatory activity of myeloid‐derived suppressor cells

  2014cites this paper
• Toward Understanding the Role of Aryl Hydrocarbon Receptor in the Immune System: Current Progress and Future Trends

  2014cites this paper
• Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice

  2014cites this paper
• Review paper Stem cell factor-dependent mast cell proliferation, maturation and activity can be regulated by inhibitory receptors

  2013cites this paper
• SyStemic maStocytoSiS in children - therapeutic problems układowa mastocytoza u dzieci - problemy terapeutyczne

  2013cites this paper
• Complex chemoattractive and chemorepellent Kit signals revealed by direct imaging of murine mast cells in microfluidic gradient chambers.

  2013cites this paper
• SHP2/PTPN11 PROTEIN-TYROSINE PHOSPHATASE PROMOTES MAST CELL HOMEOSTASIS AND SYSTEMIC MASTOCYTOSIS

  2013influential citation
• Mast cells and vascular diseases.

  2013cites this paper
• Systemic mastocytosis in children - therapeutic problems.

  2013cites this paper
• Indolent systemic mastocytosis: a case and review of the current available treatment options.

  2013influential citation